Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity.
Agar M, Koh ES, Gibbs E, Barnes EH, Hovey E, Livingstone A, Sawkins K, Chye R, Lovell MR, Clark K, Vardy J, King M; Cooperative Trials Group for Neuro-Oncology (COGNO). Agar M, et al. Among authors: barnes eh. Support Care Cancer. 2016 Mar;24(3):1209-18. doi: 10.1007/s00520-015-2897-0. Epub 2015 Aug 21. Support Care Cancer. 2016. PMID: 26294320
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.
Field KM, Simes J, Nowak AK, Cher L, Wheeler H, Hovey EJ, Brown CS, Barnes EH, Sawkins K, Livingstone A, Freilich R, Phal PM, Fitt G; CABARET/COGNO investigators; Rosenthal MA. Field KM, et al. Among authors: barnes eh. Neuro Oncol. 2015 Nov;17(11):1504-13. doi: 10.1093/neuonc/nov104. Epub 2015 Jun 30. Neuro Oncol. 2015. PMID: 26130744 Free PMC article. Clinical Trial.
The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET).
Field KM, Phal PM, Fitt G, Goh C, Nowak AK, Rosenthal MA, Simes J, Barnes EH, Sawkins K, Cher LM, Hovey EJ, Wheeler H. Field KM, et al. Among authors: barnes eh. Cancer. 2017 Sep 15;123(18):3576-3582. doi: 10.1002/cncr.30838. Epub 2017 Jul 5. Cancer. 2017. PMID: 28678383 Free article. Clinical Trial.
Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trial.
Field KM, Fitt G, Rosenthal MA, Simes J, Nowak AK, Barnes EH, Sawkins K, Goh C, Moffat BA, Salinas S, Cher L, Wheeler H, Hovey EJ, Phal PM; CABARET/COGNO Investigators. Field KM, et al. Among authors: barnes eh. Asia Pac J Clin Oncol. 2018 Oct;14(5):e359-e365. doi: 10.1111/ajco.12806. Epub 2017 Nov 8. Asia Pac J Clin Oncol. 2018. PMID: 29114999 Clinical Trial.
Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial.
Hovey EJ, Field KM, Rosenthal MA, Barnes EH, Cher L, Nowak AK, Wheeler H, Sawkins K, Livingstone A, Phal P, Goh C, Simes J; CABARET/COGNO investigators. Hovey EJ, et al. Among authors: barnes eh. Neurooncol Pract. 2017 Sep;4(3):171-181. doi: 10.1093/nop/npw025. Epub 2017 May 25. Neurooncol Pract. 2017. PMID: 31386014 Free PMC article.
A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study.
Sim HW, McDonald KL, Lwin Z, Barnes EH, Rosenthal M, Foote MC, Koh ES, Back M, Wheeler H, Sulman EP, Buckland ME, Fisher L, Leonard R, Hall M, Ashley DM, Yip S, Simes J, Khasraw M. Sim HW, et al. Among authors: barnes eh. Neuro Oncol. 2021 Oct 1;23(10):1736-1749. doi: 10.1093/neuonc/noab111. Neuro Oncol. 2021. PMID: 33984151 Free PMC article. Clinical Trial.
Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma.
Kong BY, Sim HW, Barnes EH, Nowak AK, Hovey EJ, Jeffree R, Harrup R, Parkinson J, Gan HK, Pinkham MB, Yip S, Hall M, Tu E, Carter C, Koh ES, Lwin Z, Dowling A, Simes JS, Gedye C. Kong BY, et al. Among authors: barnes eh. BMJ Open. 2022 Sep 14;12(9):e058107. doi: 10.1136/bmjopen-2021-058107. BMJ Open. 2022. PMID: 36104135 Free PMC article.
Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind study.
Agar MR, Nowak AK, Hovey EJ, Barnes EH, Simes J, Vardy JL, Wheeler HR, Kong BY, Leonard R, Hall M, Tim E, Spyridopoulos D, Sim HW, Lwin Z, Dowling A, Harrup R, Jennens R, Kichenadasse G, Dunlop T, Gzell C, Koh ES. Agar MR, et al. Among authors: barnes eh. BMJ Support Palliat Care. 2023 Sep;13(3):354-362. doi: 10.1136/spcare-2022-004119. Epub 2023 Feb 17. BMJ Support Palliat Care. 2023. PMID: 36807048 Clinical Trial.
131 results